Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 7;11(7):2670-80.
doi: 10.3390/ijms11072670.

Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India

Affiliations

Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India

Muthuraj Muthaiah et al. Int J Mol Sci. .

Abstract

Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemotherapy against Mycobacterium tuberculosis. In this study, PCR mediated automated DNA sequencing is used to check the prevalence of PZA resistance among treatment failure cases of pulmonary tuberculosis. Out of 50 clinical isolates examined, 39 had mutations in the pncA gene that encodes Pyrazinamidase, an enzyme required to activate PZA. Of these, 31 (79.5%) were localized to three regions of pncA. We found two isolates with hitherto unreported mutation at amino acid 26 (Ala-->Gly) of pncA.

Keywords: PZA resistance; South-India; mycobacterium tuberculosis; pncA mutation; pulmonary tuberculosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PCR Amplification for Species Identification. Lane 1: 100 bp DNA ladder, Lane 3:123 bp PCR amplified product.
Figure 2.
Figure 2.
PCR Amplification of pncA. Lane 1: 100 bp DNA ladder, Lane 3: 222 bp PCR amplified pncA gene product.
Figure 3.
Figure 3.
Electropherogram Analysis of PCR Amplified Products. Peak 1: Lower Marker (15 bp), Peak 2: PCR amplified product of pncA gene (222 bp) and Peak 3: Upper marker (1500 bp).

Similar articles

Cited by

References

    1. Hou L, Osei Hyiaman D, Zhang Z, Wang B, Yang A, Kano K. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol Infect. 2000;124:227–232. - PMC - PubMed
    1. Barco1 P, Cardoso RF, Hirata1 RDC, Leite CQF, Pandolfi JR, Sato DN, Shikama ML, Fiúza de Melo F, Mamizuka1 EM, Campanerut PAZ, Hirata MH. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 2006;58:930–935. - PubMed
    1. Boshoff HI, Mizrahi V. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J. Bacteriol. 2000;182:5479–5485. - PMC - PubMed
    1. Boshoff HI, Mizrahi V, Barry CE. Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase. J. Bacteriol. 2002;184:2167–2172. - PMC - PubMed
    1. Huang T, Lee SS, Tu H. Correlation between Pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob. Agents Chemother. 2003;47:3672–3673. - PMC - PubMed

MeSH terms